medigraphic.com
Coordinación General de Investigación de la Facultad de Salud Pública y Nutrición y la Dirección General de Sistemas e Informática de la Universidad Autónoma de Nuevo León

2004, Number 1

<< Back Next >>

Rev Salud Publica Nutr 2004; 5 (1)

Prevalencia, detección y tratamiento de la diabetes gestacional

Duarte-Gardea M, Muñoz G, Rodríguez-Saldaña J, Escorza- Domínguez AB

Language: Spanish
References: 50
Page:
PDF size: 78.77 Kb.


ABSTRACT

Gestational Diabetes (DMG) is the third clinical category in the current clasification of Diabetes and it represents a risk factor for women and a health problem for the baby. Diabetes Mellitus can be developed in two situations during pregnancy: 1) Women who already had Type 1 or Type 2 Diabetes Mellitus before pregnancy, and 2) Women with Diabetes during pregnancy. The most important mother complications include arterial hypertension during pregnancy, preclampsia, and eclampsia. In good conditions, the success in dealing with DMG depends on the ability, motivation, and patient's resources to reach the goals of glucemia control. Self-care plan of DMG includes nutritional and exercise plan, self-monitoring glucose, ketone test in urine and application programs of insulin in case of not reaching the goals with nopharmacological steps.


REFERENCES

  1. Duncan, M. 1882. On puerperal diabetes. Trans Obstet Soc London;24:256-285.

  2. Bennewitz HG. 1824. Symptomatic diabetes mellitus. De diabete mellito, gravitates symptomate (tesis).Universidad de Berlín.

  3. Hadden WHO Study Group.1994. Prevention of Diabetes Mellitus. Geneva, Switzerlan: World Health Organization; WHO Technical Report Series, No. 844.

  4. Metzger BE and DR Coustan 1998. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care;21(supl 2):B161-B167.

  5. Jovanovic, L and DJ Pettit. 2001 Gestational Diabetes Mellitus. JAMA;286:2516-2518.

  6. American Diabetes Association. Position Statement. 2003. Gestational Diabetes Mellitus. Definition, Detection, and Diagnosis. Diabetes Care;26:S103-S105.

  7. Coustan DR. 1995. Gestational diabetes. En: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE,Bennett PH eds. Diabetes in America. 2a ed. Baltimore, Md: National Institutes of Health;703-717. Publicación 95-1468.

  8. King H. 1998 Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care;21(supl 2):B9-B13.

  9. Hollingsworth DR, Y Vaucher and TR Yamamoto 1991. Diabetes in pregnancy in Mexican Americans. Diabetes Care;14:695-705.

  10. O Brian ME and G Gilson 1987. Detection and management of gestational diabetes in out-of-hospital birth center. Journal of Nurse-Midwifery;32:79-84

  11. Mestman J. 1980. Outcome of diabetes screening in pregnancy and perinatal morbidity in infants of mothers with mild impairment in glucose intolerance;3:447-452.

  12. Duarte-Gardea, M and JL Gonzalez 1999. Screening and diagnosis scheme for glucose intolerance and gestational diabetes in Hispanic women (resumen). Diabetes;48:466.

  13. Forsbach, G., JJ Contreras-Soto, G Fong, G Flores, and O Moreno 1988. Prevalence of gestational diabetes and macrosomic newborns in a Mexican population. Diabetes Care;11:235-238.

  14. Tamez HE, M Rodríguez, M Treviño, J Espinosa , LR Salas, J Barquet y FJ Páez 1993. Experiencia con un programa de escrutinio de diabetes gestacional [Experience with a gestational diabetes screening program]. Revista de Investigación Clínica.;45:453-456.

  15. Meza, E, L Barraza, G Martínez, V Fernández , E Ramos, C Cano, A Valdez and R Izaguirre 1995. Gestational diabetes in a Mexican-U.S. border population: Prevalence and epidemiology. Revista de Investigación Clínica.;47:433-438.

  16. López-de la Peña X, JJ Cajero-Avelar and LF de Leon-Romo 1997. Prevalence of gestational diabetes in a group of women receiving treatment at the Mexican Institute of Social Security in Aguascalientes, Mexico. Archives of Medical Research;28:281-284.

  17. O’Sullivan JB and CM Mahan 1964. Criteria for the oral glucose tolerance test in pregnancy. Diabetes; 3:278-285.

  18. Lucas MJ: 2001. Diabetes complicating pregnancy. Obstet Gynecology Clin NA ;28:513-536.

  19. Metzger, BE and DR Coustan, Op. cit.

  20. American College of Obstetricians and Gynecologists (ACOG): Shoulder dystocia. En 2000 Compendium of Selected Publications, ACOG Technical Practice Patterns No. 7. Washington DC, ACOG, 1997, p 1055.

  21. O’Sullivan JB and CM Mahan, Op. cit.

  22. Frienkel N: 1980. Gestational diabetes 1979: philosophical and practical aspects of a major public health problem. Diabetes Care;3:399-401.

  23. National Diabetes Data Group 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes;28:1039-1057.

  24. American College of Obstetricians and Gynecologists (ACOG)1986. Management of diabetes mellitus in pregnancy. ACOG Technical Bulletin No. 92, Washington DC, ACOG,.

  25. Idem.

  26. Carpenter MW, and CR Coustan 1982. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol.;144:768-773.

  27. Metzger, BE and DR Coustan, Op. cit.

  28. American College of Obstetricians and Gynecologists, Op. cit

  29. American Diabetes Association 2001. Gestational Diabetes Mellitus. Diabetes Care;24(supl 1): S77- S79.

  30. Idem.

  31. Idem.

  32. Secretaria de Salud. Norma Oficial Mexicana. 2000. NOM-015-SSA2-1994, para la prevención, tratamiento y control de la diabetes. México, Diario Oficial de la Federación. Octubre 2000.

  33. Sweeney AT and FM Brown 2001. Gestational Diabetes Mellitus. Clin Lab Med ;21:173-192.

  34. Persson B and U Hanson 1998. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care; 21(supl 2): B79-84.

  35. Idem.

  36. American Dietetic Association. Position of the American Dietetic Association: Cost-effectiveness of medical nutrition therapy. Disponible en: http://www.eatright.org/Member/PolicyInitiatives/8474_11031.cfm. Revisado en Octubre de 2003.

  37. Gunderson E. 1997.Intensive nutrition therapy for gestational diabetes. Diabetes Care; 20:221-226.

  38. Powers M. 1996. Handbook of diabetes medical nutrition therapy. Gaithersburg, MA. Aspen Publication.

  39. American Diabetes Association. Position Statement, Op. cit.

  40. Secretaría de Salud, Op. cit

  41. American Diabetes Association. Position Statement, Op. cit.

  42. Langer O. 1998. Maternal glycemic criteria for insulin therapy in gestational diabetes. Diabetes Care; 21(Supl 2): 91- 98.

  43. Carr D and S Gabbe 1998. Gestational diabetes: detection, management, and implications. Clinical Diabetes ;16:4-11.

  44. Duarte-Gardea, M. and F Harlass 2001. Treatment of gestational diabetes. El Paso Physician; 24:26- 27.

  45. Sutherland HW, JM Stowers, JD Cormack and PD Bewsher 1973. Evaluation of chlorpropamide in chemical diabetes diagnosed during pregnancy. Br Med J; 3:9-13.

  46. Anónimo. 1974. Chlorpropamide in diabetic pregnancy. Lancet ;2:32.

  47. Notflovitz M. 1974. Oral hypoglycaemic therapy in diabetic pregnancies. Lancet;2:902-903.

  48. Piacquadio K, DR Hollingsworth and H Murphy 1991. Effects of in-utero exposure to oral hypoclycaemic drugs. Lancet;866-869.

  49. Langer O, DL Conway, MD Berkus, EM Xenakis and O Gonzalez 2000. A comparison of glyburide and insulin in women with gestational diabetes mellitus. New Engl J Med;343:1134-1138.

  50. Idem.




2020     |     www.medigraphic.com